| Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans K Pafili, M Roden Molecular Metabolism 50, 101122, 2021 | 281 | 2021 |
| Metabolic liver disease in diabetes–from mechanisms to clinical trials B Dewidar, S Kahl, K Pafili, M Roden Metabolism 111, 154299, 2020 | 158 | 2020 |
| Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis S Schlesinger, M Neuenschwander, A Lang, K Pafili, O Kuss, C Herder, ... Diabetologia 64 (7), 1480-1491, 2021 | 118 | 2021 |
| Current pharmacological treatment of painful diabetic neuropathy: A narrative review V Ardeleanu, A Toma, K Pafili, N Papanas, I Motofei, CC Diaconu, ... Medicina 56 (1), 25, 2020 | 75 | 2020 |
| Abdominal aortic aneurysms and diabetes mellitus K Pafili, I Gouni-Berthold, N Papanas, DP Mikhailidis Journal of Diabetes and its Complications 29 (8), 1330-1336, 2015 | 71 | 2015 |
| Mean platelet volume and coronary artery disease K Pafili, T Penlioglou, DP Mikhailidis, N Papanas Current opinion in cardiology 34 (4), 390-398, 2019 | 66 | 2019 |
| Simplified diagnosis of cardiovascular autonomic neuropathy in type 2 diabetes using Ewing's battery K Pafili, G Trypsianis, D Papazoglou, E Maltezos, N Papanas The review of diabetic studies: RDS 12 (1-2), 213, 2015 | 61 | 2015 |
| Skin AGEs and diabetic neuropathy S Papachristou, K Pafili, N Papanas BMC Endocrine Disorders 21, 1-8, 2021 | 56 | 2021 |
| Evaluation of sural nerve automated nerve conduction study in the diagnosis of peripheral neuropathy in patients with type 2 diabetes mellitus G Chatzikosma, K Pafili, M Demetriou, D Papazoglou, K Vadikolias, ... Archives of Medical Science 12 (2), 390-393, 2016 | 51 | 2016 |
| Pharmacotherapy for gestational diabetes AM Patti, RV Giglio, K Pafili, M Rizzo, N Papanas Expert Opinion on Pharmacotherapy 19 (13), 1407-1414, 2018 | 45 | 2018 |
| Mitochondrial respiration is decreased in visceral but not subcutaneous adipose tissue in obese individuals with fatty liver disease K Pafili, S Kahl, L Mastrototaro, K Strassburger, D Pesta, C Herder, ... Journal of hepatology 77 (6), 1504-1514, 2022 | 41 | 2022 |
| The relationship between obstructive sleep apnoea and coronary heart disease K Pafili, P Steiropoulos, N Papanas Current Opinion in Cardiology 30 (4), 439-446, 2015 | 32 | 2015 |
| Neuropathy in diabetes:“one cannot begin it too soon” K Pafili, N Papanas, D Ziegler Angiology 69 (9), 752-754, 2018 | 29 | 2018 |
| Thermography in the follow up of the diabetic foot: best to weigh the enemy more mighty than he seems K Pafili, N Papanas Expert review of medical devices 12 (2), 131-133, 2015 | 23 | 2015 |
| Metabolic disorders during pregnancy and postpartum cardiometabolic risk AM Patti, K Pafili, N Papanas, M Rizzo Endocrine Connections 7 (5), E1-E4, 2018 | 22 | 2018 |
| Older people with learning disabilities: Workforce issues S Hussein, J Manthorpe Journal of Integrated Care 13 (1), 17-23, 2005 | 21* | 2005 |
| Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones K Pafili, SA Paschou, E Armeni, SA Polyzos, DG Goulis, I Lambrinoudaki Journal of Endocrinological Investigation 45 (9), 1609-1623, 2022 | 19 | 2022 |
| Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus RV Giglio, AP Stoian, M Haluzik, K Pafili, AM Patti, AA Rizvi, M Ciaccio, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1867 (8), 166148, 2021 | 19 | 2021 |
| NC-stat for the diagnosis of diabetic polyneuropathy K Pafili, E Maltezos, N Papanas Expert review of medical devices 14 (4), 251-254, 2017 | 19 | 2017 |
| The potential of SGLT2 inhibitors in phase II clinical development for treating type 2 diabetes K Pafili, E Maltezos, N Papanas Expert Opinion on Investigational Drugs 25 (10), 1133-1152, 2016 | 19 | 2016 |